Bringing the fundamentals into focus…
Back to Xeris Biopharma Holdings, Inc.
How Xeris Biopharma Holdings, Inc. stacks up
XERS · against 588 other Healthcare companies listed in US-listed
Valuation
36/ 100
Above the middle of the pack.
Ranked #250 of 589 · scores higher than 57% of peers
Bars: peers in each 10-point band of the valuation score75 peers with a valuation score of 30–39, including XERS · Click a bar to see the companies
Why valuation scores 36?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, which is weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -0.9% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 1.9% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 67% of peers. Free cash flow yield: 3.0% vs peer median 0.0%
Metric by metric
Position: dot = XERS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | XERS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -1.0% | -4.3% | 61% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 2.4% | -0.8% | 59% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 3.0% | -2.3% | 71% | 20% | |
| Book yieldHigher is better · 587 reported | -0.5% | 25.9% | 9% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around XERS| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 245 | 2.7B USD | 37 | 44 | |
| 250 | 16.5B USD | 36 | 37 | |
| 250 | 1.2B USD | 36 | 36 | |
| 250 | 3.1B USD | 36 | 53 | |
| 250 | 1.9B USD | 36 | 47 | |
| 254 | 30M USD | 33 | ||
| 254 | 205M USD | 33 | 36 | |
| 254 | 23M USD | 33 | ||
| 254 | 642M USD | 33 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score